Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

Completed · Phase 3

Conditions studied: Myocardial Infarction

In brief

This study evaluated differences between men and women in the presentation, management and outcome of heart attacks within the GUSTO V study.

Key facts

Study ID

NCT00245648

Run by

NYU Langone Health

Starts

2001-06-01

Expected to finish

2007-10-01

Last updated by the study team

2012-10-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• inclusion into GUSTO V

You may not qualify if…

• lack of availability of data (database study)

Where it is running

• NYU School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.